Improved methods and systems for diagnosing and for treating Cushing's syndrome and Cushing's Disease are provided herein, including methods and systems for concurrently treating Cushing's syndrome and differentially diagnosing Cushing's Disease from Ectopic Cushing's Syndrome in a patient with an established diagnosis of ACTH-dependent Cushing's syndrome. Treatment methods can use glucocorticoid receptor antagonists (GRAs), which differentially affect the ratio of cortisol to ACTH levels in patients having Cushing's Disease versus patients having Ectopic Cushing's Syndrome. Methods for concurrently treating and differentially diagnosing Cushing's Disease from Ectopic Cushing's Syndrome include obtaining baseline cortisol and ACTH levels of a patient, treating the patient with a GRA according to a protocol that would typically substantially elevate cortisol levels, obtaining post-treatment cortisol and ACTH levels of the patient, determining a differential relationship between baseline cortisol and ACTH levels and post-treatment cortisol and ACTH levels and providing a positive diagnosis based on the differential relationship.

Provided herein are methods for detecting neutralizing antibodies to leptins, including metreleptin, as well as identifying subjects having such neutralizing antibodies.

Provided herein are methods for detecting neutralizing antibodies to leptins, including metreleptin, as well as identifying subjects having such neutralizing antibodies.

Provided is a method for sensing methyl salicylate, which is a plant hormone released when a plant is infected with a disease in cultivation of plants including agricultural crops, and thereby provided a method for early in-situ detection of disease infection in a plant. With the present embodiment, disease infection in a plant can be detected at an early stage by utilizing a rare earth compound that selectively recognizes and forms a complex with methyl salicylate, which is a plant hormone released when a plant is infected by a pathogen, as a receptor for sensing, and by utilizing a fluorescence emission phenomenon and a change in electrochemical behavior after the reaction with methyl salicylate.

Provided is a method for sensing methyl salicylate, which is a plant hormone released when a plant is infected with a disease in cultivation of plants including agricultural crops, and thereby provided a method for early in-situ detection of disease infection in a plant. With the present embodiment, disease infection in a plant can be detected at an early stage by utilizing a rare earth compound that selectively recognizes and forms a complex with methyl salicylate, which is a plant hormone released when a plant is infected by a pathogen, as a receptor for sensing, and by utilizing a fluorescence emission phenomenon and a change in electrochemical behavior after the reaction with methyl salicylate.

The present invention relates to a method of providing a FAS finding (30) for the functionality of an anorexigenic signal path for a patient, comprising the steps: providing a sample matrix (10) of a body substance of the patient, determining at least one first FAS indicator (11) from the sample matrix (10), determining at least one second FAS indicator (12) from the sample matrix (10), wherein the at least one second FAS indicator (12) is different from the at least one first FAS indicator (11), and generating the FAS finding (30) using an indicator spectrum (20) comprising the at least one first FAS indicator (11) and the at least one second FAS indicator (12). The invention also relates to an analysis device (100) for providing a FAS finding (30) with a computer program product according to the invention (90) and a storage means (80) with a computer program product (90) according to the invention stored thereon.

The present invention relates to a method of providing a FAS finding (30) for the functionality of an anorexigenic signal path for a patient, comprising the steps: providing a sample matrix (10) of a body substance of the patient, determining at least one first FAS indicator (11) from the sample matrix (10), determining at least one second FAS indicator (12) from the sample matrix (10), wherein the at least one second FAS indicator (12) is different from the at least one first FAS indicator (11), and generating the FAS finding (30) using an indicator spectrum (20) comprising the at least one first FAS indicator (11) and the at least one second FAS indicator (12). The invention also relates to an analysis device (100) for providing a FAS finding (30) with a computer program product according to the invention (90) and a storage means (80) with a computer program product (90) according to the invention stored thereon.

Described herein are methods and compositions for treating or preventing an allergy or anaphylaxis. Certain aspects of the invention relate to administering to a subject an agent that inhibits RELMβ.

Described herein are methods and compositions for treating or preventing an allergy or anaphylaxis. Certain aspects of the invention relate to administering to a subject an agent that inhibits RELMβ.

A device for processing samples is disclosed. Interior surfaces of the device, which come in contact with fluids, define wetted surfaces. A portion of the wetted surfaces are coated with an alkylsilyl coating having the Formula I: ##STR00001##
R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are each independently selected from (C.sub.1-C.sub.6)alkoxy, —NH(C.sub.1-C.sub.6)alkyl, —N((C.sub.1-C.sub.6)alkyl).sub.2, OH, OR.sup.A, and halo. R.sup.A represents a point of attachment to the interior surfaces of the fluidic system. At least one of R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 is OR.sup.A. X is (C.sub.1-C.sub.20)alkyl, —O[(CH.sub.2).sub.2O].sub.1-20—, —(C.sub.1-C.sub.10)[NH(CO)NH(C.sub.1-C.sub.10)].sub.1-20—, or —(C.sub.1-C.sub.10)[alkylphenyl(C.sub.1-C.sub.10)alkyl].sub.1-20—.